# Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
Canonical URL: https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-bofa-securities-2026-health-care-conference
Ticker: SRRK
Company: Scholar Rock
Source: Scholar Rock
Published: 2026-04-29 12:00 EST
Original Source URL: https://investors.scholarrock.com
## Summary

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 29, 2026-- Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading

## Article Body
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 29, 2026-- Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading
## Recent Company News
- 2026-05-26 13:30 EST — [Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference](https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference) — Source: Scholar Rock
- 2026-05-20 12:00 EST — [Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-2026-jefferies-global-healthcare-conference) — Source: Scholar Rock
- 2026-05-07 11:00 EST — [Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights](https://biopharmsignal.com/news/SRRK/scholar-rock-reports-first-quarter-2026-financial-results-and-recent-business-highlights) — Source: Scholar Rock
- 2026-04-29 12:00 EST — [Scholar Rock to Present at the BofA Securities 2026 Health Care Conference](https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-bofa-securities-2026-health-care-conference) — Source: Scholar Rock
- 2026-04-17 20:15 EST — [Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/SRRK/scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Scholar Rock
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)